NHS England. Implementing a timed prostate cancer diagnostic pathway. A handbook for local health and care systems. 2018. (accessed 28 July 2021)

West Midlands Cancer Alliance. Prostate cancer personalised stratified follow up pathway guidelines. 2019. (accessed 28 July 2021)

Improving the pathway for men with suspected prostate cancer

12 August 2021
6 min read
Volume 30 · Issue 15


Kelly Kusinski, Urology Advanced Nurse Practitioner, The Royal Wolverhampton NHS Trust (, runner-up in the Urology Nurse of the Year category in the BJN Awards 2021

Over the past 3 years, I have been dedicated to helping redesign the patient pathway for men with suspected prostate cancer at my trust. I had already undertaken elevated prostate-specific antigen (PSA) assessment and transrectal ultrasound-guided prostate biopsies, so was in a good position to lead on these changes.

Back in 2018, achieving the new faster diagnostic standard for prostate cancer by April 2020 required the communication of a cancer diagnosis, or the ruling out of cancer, to the patient within 28 days from referral from their GP (NHS England, 2018). Prostate cancer is now the most common cancer diagnosed in men in the UK. Increasing numbers of referrals presented a real challenge for most NHS trusts to achieve this new best practice pathway. Within my own trust the same patient pathway was in excess of 43 days. It was therefore identified that improvements in the current pathway would be required to meet the new diagnostic target.

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content